Eledon Pharmaceuticals (ELDN) vs Entrada Therapeutics (TRDA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Entrada Therapeutics (TRDA) has outperformed Eledon Pharmaceuticals (ELDN) over the past year, losing 10.2% versus a loss of 15.7%. Entrada Therapeutics is the larger company by market cap ($215.3 million vs $196.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELDN | TRDA |
|---|---|---|
| Share price | $2.42 | $5.53 |
| Market cap | $196.65M | $215.32M |
| 1-day change | 0.00% | -1.43% |
| YTD return | +60.26% | -46.21% |
| 1-year return | -15.68% | -10.23% |
| 5-year return | -57.02% | — |
| EPS (TTM) | $-0.90 | $-3.90 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.60 | $16.45 |
| 52-week low | $1.35 | $5.15 |
| Distance from 52-week high | -47.39% | -66.38% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +271.90% | +243.58% |
| Average volume | 935.08K | 359.01K |
| Shares outstanding | 81.26M | 38.94M |
| Employees | 33 | 152 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Eledon Pharmaceuticals
ELDN stock →Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees
About Entrada Therapeutics
TRDA stock →Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 152 employees
ELDN vs TRDA FAQ
Which is bigger, Eledon Pharmaceuticals or Entrada Therapeutics?
Entrada Therapeutics (TRDA) is larger, with a market capitalization of $215.32M compared with $196.65M for Eledon Pharmaceuticals (ELDN).
Which stock has performed better over the past year, ELDN or TRDA?
TRDA returned -10.23% over the past 12 months, compared with -15.68% for ELDN (price return, excluding dividends). Past performance does not predict future results.
Are Eledon Pharmaceuticals and Entrada Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.